CPIX
Cumberland Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
7.46 / 10
Outperform
Analyst coverage is missing (ana_eval -1). Fund‑flow rating is strong at 7.46/10, classified good. Small and Large investors show positive trends, while overall and block flows are negative. The mixed pattern suggests capital interest but potential volatility.
Fund Flow Rating
What is the market sentiment for CPIX?
- CPIX holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.46/10 (Outperform).
